Three recent moves show how stalled drug developers are funneling cash back to investors, either as they close up shop or pursue new strategies.

The Better Meat Co. has received a new patent for its process to create a shelf-stable high-protein ingredient out of potato-processing leftovers. The Better Meat Co. has received a new patent for its ...